loadpatents
name:-0.010020971298218
name:-0.010776996612549
name:-0.00042319297790527
Parczyk; Karsten Patent Filings

Parczyk; Karsten

Patent Applications and Registrations

Patent applications and USPTO patent grants for Parczyk; Karsten.The latest application filed is for "anti-androgenic pyrrolidines with tumor-inhibiting action".

Company Profile
0.9.5
  • Parczyk; Karsten - Berlin DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-androgenic pyrrolidines with tumor-inhibiting action
Grant 7,601,748 - Cleve , et al. October 13, 2
2009-10-13
Anti-androgenic pyrrolidines with tumor-inhibiting action
App 20070021481 - Cleve; Arwed ;   et al.
2007-01-25
Anti-androgenic pyrrolidines with tumor-inhibiting action
Grant 7,138,421 - Cleve , et al. November 21, 2
2006-11-21
Antiestrogens, process for their production and their pharmaceutical use
Grant 7,074,829 - Klar , et al. July 11, 2
2006-07-11
Thiazolidinones and the use therof as polo-like kinase inhibitors
App 20060079503 - Schwede; Wolfgang ;   et al.
2006-04-13
Anti-androgenic pyrrolidines with tumor-inhibiting action
App 20050159468 - Cleve, Arwed ;   et al.
2005-07-21
11.beta.-HALOGEN-7.alpha.-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11.beta.-HALOGEN-7.alpha.-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS
Grant 6,780,855 - Bohlmann , et al. August 24, 2
2004-08-24
New7.alpha., 17.alpha.-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases
Grant 6,767,903 - Cleve , et al. July 27, 2
2004-07-27
New antiestrogens, process for their production and their pharmaceutical use
App 20030162830 - Klar, Ulrich ;   et al.
2003-08-28
11beta-halogen-7alpha-substituted Estratrienes, Metod For Producing Pharmaceutical Preparations Containing Said 11beta-halogen-7alpha- Substituted Estratrienes And Use Of The Same For Producing Medicaments
App 20030069434 - BOHLMANN, ROLF ;   et al.
2003-04-10
7 .alpha.-(5-methylaminopentyl)-estratrienes, process for their production, pharmaceutical preparations that contain these 7 .alpha.(5-methylaminopentyl)-estratrienes as well as their use for the production of pharmaceutical agents
Grant 6,288,051 - Bittler , et al. September 11, 2
2001-09-11
7.alpha.-(xi-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7.alpha.-(xi-aminoalkyl-estratrienes as well as their use for the production of pharmaceutical agents
Grant 6,271,403 - Bohlmann , et al. August 7, 2
2001-08-07
7.alpha.-(.xi.-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7.alpha.-(.xi.-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agents
Grant 5,866,560 - Bohlmann , et al. February 2, 1
1999-02-02
Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents
Grant 5,807,899 - Bohlmann , et al. September 15, 1
1998-09-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed